Searched over 200M research papers
10 papers analyzed
Some studies suggest metformin can lower blood pressure, especially in certain populations like obese or hypertensive individuals, while other studies indicate it has no significant effect on blood pressure.
11 papers analyzed
20 papers analyzed
Metformin is a widely used medication primarily prescribed for managing type 2 diabetes. It is known for its glucose-lowering effects, but its impact on blood pressure (BP) has been a subject of research. This article synthesizes findings from various studies to determine whether metformin can raise blood pressure.
Several studies have investigated the effects of metformin on blood pressure in non-diabetic individuals. A double-blind, placebo-controlled study found that metformin did not decrease 24-hour ambulatory or office blood pressure in non-diabetic, moderately obese, hypertensive patients. Similarly, another clinical trial with hypertensive patients without diabetes reported no significant difference in BP reduction between the metformin and placebo groups. These findings suggest that metformin does not raise blood pressure in non-diabetic hypertensive individuals.
In diabetic patients, the effects of metformin on blood pressure appear to be more complex. A systematic review and meta-analysis of randomized controlled trials indicated that metformin had no significant effect on diastolic blood pressure (DBP) but did show a modest reduction in systolic blood pressure (SBP). Another study highlighted that metformin might adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes, indicating a potential increase in BP upon standing.
A study focusing on obese, hypertensive women found that metformin treatment significantly decreased both systolic and diastolic blood pressure, along with improvements in glucose metabolism and lipid profiles. This suggests that in certain populations, metformin may have a beneficial effect on blood pressure.
Animal studies have also provided insights into metformin's effects on blood pressure. In fructose-fed hypertensive rats, metformin prevented the increase in systolic blood pressure induced by a high-fructose diet. Additionally, in spontaneously hypertensive rats, metformin attenuated salt-induced hypertension, indicating its potential to lower blood pressure in specific hypertensive conditions.
The current body of research indicates that metformin does not raise blood pressure in non-diabetic individuals and may even lower it in certain populations, such as obese, hypertensive women and specific animal models. However, in diabetic patients, metformin's effects on blood pressure can vary, with some studies suggesting potential adverse effects on orthostatic blood pressure recovery. Overall, metformin's impact on blood pressure is nuanced and appears to depend on the specific patient population and underlying health conditions.
Most relevant research papers on this topic